Literature DB >> 12107192

Somatostatin analogs in acromegaly.

Pamela U Freda1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12107192     DOI： 10.1210/jcem.87.7.8665

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  79 in total

Review 1.  Growth hormone and its disorders.

Authors:  J Ayuk; M C Sheppard
Journal:  Postgrad Med J       Date:  2006-01       Impact factor: 2.401

Review 2.  GH receptor antagonist: mechanism of action and clinical utility.

Authors:  Sowmya K Surya; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2005-01       Impact factor: 6.514

3.  Treatment of pituitary tumors: history.

Authors:  Gaya Thanabalasingham; Niki Karavitaki; Simon Cudlip; John A H Wass
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

4.  Poor responses to a test dose of subcutaneous octreotide predict the need for adjuvant therapy to achieve 'safe' growth hormone levels.

Authors:  J R Lindsay; E M McConnell; S J Hunter; D R McCance; B Sheridan; A B Atkinson
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  First-line therapy of acromegaly: a statement of the A.L.I.C.E. (Acromegaly primary medical treatment Learning and Improvement with Continuous Medical Education) Study Group.

Authors:  A Colao; E Martino; P Cappabianca; R Cozzi; M Scanarini; E Ghigo
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

6.  Comparison of pegvisomant and long-acting octreotide in patients with acromegaly naïve to radiation and medical therapy.

Authors:  E Ghigo; B M K Biller; A Colao; I A Kourides; N Rajicic; R K Hutson; L De Marinis; A Klibanski
Journal:  J Endocrinol Invest       Date:  2009-12-04       Impact factor: 4.256

Review 7.  Acromegaly.

Authors:  Massimo Scacchi; Francesco Cavagnini
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

8.  Cost-of-illness study in acromegalic patients in Italy.

Authors:  G Didoni; S Grottol; V Gasco; M Battistini; D Ferone; M Giusti; F Ragazzoni; P Ruffo; E Ghigo; F Minuto
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

9.  Treatment of acromegaly with SS analogues: should GH and IGF-I target levels be lowered to assert a tight control of the disease?

Authors:  R Cozzi; R Attanasio; S Grottoli; G Pagani; P Loli; V Gasco; A M Pedroncelli; M Montini; E Ghigo
Journal:  J Endocrinol Invest       Date:  2004-12       Impact factor: 4.256

Review 10.  Guidelines for the treatment of growth hormone excess and growth hormone deficiency in adults.

Authors:  A Giustina; A Barkan; P Chanson; A Grossman; A Hoffman; E Ghigo; F Casanueva; A Colao; S Lamberts; M Sheppard; S Melmed
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.